Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
1.
Med Phys ; 25(5): 746-9, 1998 May.
Article in English | MEDLINE | ID: mdl-9608486

ABSTRACT

A routine diode in vivo dosimetry program based on a combination of entrance and exit dose measurements was clinically implemented in the radiation oncology department of Grace Hospital, Detroit, in January 1995. The delivered dose has been monitored by taking weekly measurements. The calibration of the diodes and the in vivo dosimetry protocol for this new, more effective type of dose verification is presented. The problems encountered within the program are discussed along with our solutions.


Subject(s)
Radiotherapy Planning, Computer-Assisted , Calibration , Equipment Design , Phantoms, Imaging , Polystyrenes , Radiation Oncology/instrumentation , Radiation Oncology/methods , Radiotherapy Dosage , Radiotherapy Planning, Computer-Assisted/instrumentation , Radiotherapy Planning, Computer-Assisted/methods
2.
Int J Radiat Oncol Biol Phys ; 34(1): 173-81, 1996 Jan 01.
Article in English | MEDLINE | ID: mdl-12118548

ABSTRACT

PURPOSE: Radiochromic film was used to measure and compare the dose distributions parallel to a high dose rate (HDR) 192Iridium (192Ir) brachytherapy afterloading catheter that resulted from optimized treatment plans using various combinations of prescribed dose magnitude and location as well as source spacing. METHODS AND MATERIALS: Differences exist among clinical investigators for specification of the magnitude and location of prescribed treatment dose for brachytherapy irradiations using HDR 192Ir afterloading. Typical prescriptions for endobronchial irradiation include 5 to 10 Gy at 10 mm or 15 Gy at 6 mm measured from the center of the afterloading catheter. The dose distributions that result from these irradiations are very difficult to quantify by conventional dosimetry methods. This study used radiochromic film to measure the dose distributions resulting from optimized treatment plans for source dwell position separations of 2.5 or 5.0 mm and for a prescribed treatment dose of either 15 Gy at 6 mm or 5 Gy at 10 mm, conditions that have been used at M. D. Anderson Cancer Center for the treatment of endobronchial lesions. An acrylic phantom was designed to allow for measurement of the dose distributions at 0.95 mm (catheter surface), 6 mm, and 10 mm from and parallel to the catheter for sources positioned along either 20 or 80 mm of the catheter. RESULTS: Radiochromic film is shown to be a suitable quality assurance and dosimetry modality for the measurement of the dose distribution along an afterloading catheter resulting from an HDR I92Ir source. Each of the treatment plans was about equally effective in being able to produce a uniform dose distribution at their respective planned target distances. Differences were more apparent when comparing the dose distributions at nontargeted distances. On the catheter surface the dose was very nonuniform and in the case of 2.5 mm source spacing along 20 mm of catheter with target dose planned to 10 mm, the central minimum dose was only 13 to 24% of the dose opposite to the most proximal and distal sources. The absolute doses measured at equivalent distances for the 15 Gy planned to 6 mm treatments are about 1.3 to 1.5 times higher than those measured for the 5 Gy planned to 10 mm treatments. It was also observed that the lateral positioning of the encapsulated source within the afterloading catheter can contribute to dose differences about the catheter that are greatest for measurements made in contact with the catheter surface (24 to 40%) but may also be large at the treatment planning distances of 6 (0 to 15%) and 10 mm (0 to 9%). CONCLUSION: At their respective treatment planning distances of 6 or 10 mm, each of the treatment plans produced dose distributions of comparable uniformity. Against the catheter, relatively more uniform dose distributions with higher minimum doses were obtained for (a) dose prescription at 6 mm, rather than at 10 mm; (b) source separation of 2.5 mm, rather than 5.0 mm (except for a 20 mm active catheter length with dose planned to 10 mm); and (c) longer active length of the catheter of 80 mm, rather than 20 mm.


Subject(s)
Brachytherapy , Iridium Radioisotopes/therapeutic use , Radiometry/methods , X-Ray Film , Humans , Phantoms, Imaging , Quality Control , Radiometry/instrumentation , Radiotherapy Dosage
3.
Int J Radiat Oncol Biol Phys ; 33(3): 725-46, 1995 Oct 15.
Article in English | MEDLINE | ID: mdl-7558965

ABSTRACT

Intraoperative radiation therapy (IORT) is a treatment modality whereby a large single dose of radiation is delivered to a surgically open, exposed cancer site. Typically, a beam of megavoltage electrons is directed at an exposed tumor or tumor bed through a specially designed applicator system. In the last few years, IORT facilities have proliferated around the world. The IORT technique and the applicator systems used at these facilities vary greatly in sophistication and design philosophy. The IORT beam characteristics vary for different designs of applicator systems. It is necessary to document the existing techniques of IORT, to detail the dosimetry data required for accurate delivery of the prescribed dose, and to have a uniform method of dose specification for cooperative clinical trials. The specific charge to the task group includes the following: (a) identify the multidisciplinary IORT team, (b) outline special considerations that must be addressed by an IORT program, (c) review currently available IORT techniques, (d) describe dosimetric measurements necessary for accurate delivery of prescribed dose, (e) describe dosimetric measurements necessary in documenting doses to the surrounding normal tissues, (f) recommend quality assurance procedures for IORT, (g) review methods of treatment documentation and verification, and (h) recommend methods of dose specification and recording for cooperative clinical trials.


Subject(s)
Electrons/therapeutic use , Neoplasms/radiotherapy , Combined Modality Therapy , Hospitals, Special , Humans , Intraoperative Period , Neoplasms/surgery , Particle Accelerators , Patient Care Team , Quality of Health Care , Radiotherapy Dosage , Radiotherapy, High-Energy
4.
Ann Surg Oncol ; 1(5): 415-22, 1994 Sep.
Article in English | MEDLINE | ID: mdl-7850543

ABSTRACT

BACKGROUND: We compared treatment-related charges associated with external beam irradiation and interstitial implantation for soft-tissue sarcoma of the extremity. METHODS: Charges related to radiotherapy in 35 patients with soft-tissue sarcoma of the extremity were reviewed. Preoperative external beam irradiation (EB) delivering 50 Gy in 25 fractions with 6 MV photons was administered to 12 of the patients evaluated. The remaining 23 patients were treated with interstitial implantation (IR) as the only radiotherapeutic intervention. The anatomic distribution of the sarcomas treated by IR included 14 lower-extremity (LE) and nine upper-extremity (UE) lesions. The average length of iridium wire used for IR was 78 cm. Because LE lesions tend to be larger, the average length equaled 109.5 cm as compared with the 47 cm for UE implants. RESULTS: The radiotherapeutic approach represented the only difference in treatment-related charges because the operative procedure of wide local excision was performed in each group. No difference in perioperative complications was observed between the two treatment approaches. Charges were stratified according to hospital-based and professional services. Radiotherapy-based hospital charges for the administration of EB averaged $6,515 compared with $4,050 for IR (p < 0.0001). Professional services also were significantly different, totaling $4,390 for EB and $3,240 for IR (p < 0.0001). The total of these charges for radiotherapy procedures and professional fees equaled $10,905 for EB compared with $7,290 for IR (p < 0.0001). Incorporating the necessary operating-room time for implant placement ($750) and five additional hospital days ($1,800), the costs associated with IR totaled $9,840; using chi-square analysis, the cost for IR remained significantly (p < 0.0001) less expensive than the $10,905 associated with EB. Because a large component of the radiotherapy cost for IR is related to the length of iridium 192 wire required, charges were stratified according to the location of the tumor. The total charge for IR of the UE equaled $9,345 compared with $10,335 for LE implants. Chi-square comparison for both UE and LE implants continued to show significant differences (p < 0.0001) when related to EB therapy. CONCLUSION: Cost-analysis comparison of brachytherapy versus external beam irradiation found lower charges for patients undergoing adjuvant irradiation with brachytherapy for soft-tissue sarcoma. To optimize the cost-benefit ratio, prospective studies are necessary to define the application of these radiotherapeutic approaches based on clinical criteria.


Subject(s)
Arm , Brachytherapy/economics , Fees and Charges , Leg , Radiotherapy, High-Energy/economics , Sarcoma/radiotherapy , Soft Tissue Neoplasms/radiotherapy , Combined Modality Therapy , Cost-Benefit Analysis , Costs and Cost Analysis , Hospital Charges , Humans , Preoperative Care , Radiotherapy, Adjuvant/economics , Sarcoma/surgery , Soft Tissue Neoplasms/surgery
5.
Med Phys ; 21(4): 559-66, 1994 Apr.
Article in English | MEDLINE | ID: mdl-8058023

ABSTRACT

This work evaluates the application of AAPM task group 25 (TG25) methodology for determination of central axis depth dose for a radiotherapy linear accelerator, whose dual scattering foil system and applicators were recently modified. The percent depth dose (%DD) and the dose output factor have been measured for square and rectangular fields at 100- and 110-cm source-to-surface distance (SSDs). At 100-cm SSD, results showed that %DD for a specific energy and field size can vary with applicator, the largest variation being for the 20-MeV, 10 x 10-cm field where a spread of +/- 2.5% or +/- 3 mm about the mean %DD is observed. The square-root method determines rectangular field %DD within 1%. Output factors for rectangular fields are calculated from square field values more accurately using a square-root method than the equivalent-square method recommended by TG25. At 110-cm SSD, the %DD calculated from that at 100-cm SSD using an inverse square factor does not agree with measured values for all fields. The maximum difference observed for the 20-MeV, 6 x 6-cm field was 5.5% or 10 mm. Output data at the 110-cm SSD show that the square-root method is suitable for determination of the air-gap correction factors of rectangular fields. In summary, the recommendations of TG25 work reasonably well for central axis electron beam dosimetry for this version of a radiotherapy linear accelerator, except in limited cases where applicator-scattered electrons apparently cause minor but clinically significant discrepancies.


Subject(s)
Particle Accelerators , Radiotherapy Planning, Computer-Assisted/methods , Biophysical Phenomena , Biophysics , Electrons , Evaluation Studies as Topic , Humans , Radiotherapy Dosage , Radiotherapy, High-Energy/methods
6.
Int J Radiat Oncol Biol Phys ; 28(3): 667-71, 1994 Feb 01.
Article in English | MEDLINE | ID: mdl-8113110

ABSTRACT

PURPOSE: Recent studies of human cell lines cultured in vitro and mathematical modeling of the response of acute and late responding tissues have predicted conditions for the equivalence in terms of cell killing of continuous and pulsed dose rate brachytherapy. The aim of this study was to test these predictions in vivo using an acutely responding normal tissue. METHODS AND MATERIALS: The microcolony assay was used to quantify the survival of jejunal stem cells in vivo. Mice were exposed to graded doses of 60Co delivered continuously or as 1- or 10-min pulses given once-per-hour at an average dose rate of 0.7 Gy/hr. In both cases the total dose-per-hour was 0.7 Gy. Overall exposure times ranged between about 30 and 60 h. Mice were sacrificed 3.5 days after exposure, the bowel removed for routine histological preparation, and number of surviving crypts quantified microscopically. RESULTS: An average dose-per-hour of 0.7 Gy, a pulse width of 10 min, and a pulse frequency of 1 h resulted in biological equivalence of pulsed to continuous treatment. Delivering the pulse in a period of 1 min at a dose rate 10-fold higher resulted in a modest 3-4% shift in the survival curve to lower isoeffective doses. The slopes of the survival curves as described by D(o) values were similar for all treatment regimens tested. CONCLUSION: This in vivo study validates the prediction of biological equivalence between pulsed and continuous brachytherapy at a clinically relevant average dose rate and may generate further interest in this new treatment modality because of its advantages in radiation protection, dose optimization, and cost relative to standard low dose rate brachytherapy techniques.


Subject(s)
Brachytherapy/methods , Animals , Cell Survival/radiation effects , Dose-Response Relationship, Radiation , Female , Intestinal Mucosa/radiation effects , Iridium Radioisotopes , Jejunum/radiation effects , Mice , Radiotherapy Dosage , Time Factors
7.
Bone Marrow Transplant ; 14 Suppl 4: S4-8, 1994.
Article in English | MEDLINE | ID: mdl-7728124

ABSTRACT

The first bone marrow transplants (BMTs) in human patients were performed after conditioning with total body irradiation (TBI). TBI remains an important part of BMT protocols. The morbidity and mortality of BMT remains significant, but can be decreased by the introduction of optimized TBI regimens. This requires dosimetric control and a detailed analysis and description of the physics of the TBI procedure in every BMT center that utilizes TBI. Recommendations for such procedures are given. Radiobiological models are of help in developing less toxic TBI procedures, but can only be effective after dosimetric control has been obtained and if the influence of other variables on the outcome of BMT are taken into account. Fractionated TBI (fraction size over 3.0 Gy or higher) appears to be more effective and better tolerated than single fraction TBI. Lung shielding is possible during TBI. Smaller organs or organs that cannot be imaged easily are not recommended for shielding. Radiolabeled immunoglobulins are but low molecular weight bone seeking radioisotopes and are not expected to improve the therapeutic ratio of TBI. Other variables in BMT are more difficult to quantify and model than TBI (e.g. high-dose chemotherapy, graft-versus-host disease) and will be more difficult to optimize.


Subject(s)
Bone Marrow Transplantation/methods , Whole-Body Irradiation , Animals , Dogs , Dose-Response Relationship, Radiation , Graft Rejection , Graft vs Host Disease , Humans , Lung/radiation effects , Macaca mulatta , Neoplasms/mortality , Neoplasms/therapy , Pilot Projects , Radiation Injuries/prevention & control , Radiation Protection , Radioimmunotherapy , Radiotherapy Dosage , Swine , Swine, Miniature , Whole-Body Irradiation/adverse effects , Whole-Body Irradiation/methods , Whole-Body Irradiation/mortality
8.
Ann Surg ; 218(1): 54-60, 1993 Jul.
Article in English | MEDLINE | ID: mdl-8101073

ABSTRACT

OBJECTIVE: To determine the morbidity and mortality of pancreaticoduodenectomy followed by electron-beam intraoperative radiation therapy (EB-IORT). SUMMARY BACKGROUND DATA: Local recurrence following pancreaticoduodenectomy occurs in 50% to 90% of patients who undergo a potentially curative surgical resection for adenocarcinoma of the pancreatic head. To improve local disease control, a more aggressive retroperitoneal dissection has been combined with adjuvant EB-IORT. METHODS: Forty-one patients with malignant neoplasms of the periampullary region underwent pancreaticoduodenectomy followed by EB-IORT between January 1989 and May 1992. EB-IORT was delivered in a dedicated operative suite, eliminating the need for patient relocation. Electron-beam energies of 6 to 12 MeV were used to deliver 10 to 20 Gy to the treatment field following resection but before pancreatic, biliary, and gastrointestinal reconstruction. RESULTS: Median operative time was 9 hours, blood loss was 1 L, perioperative transfusion requirement was 2 units, and hospital stay was 20 days. One patient died of a postoperative myocardial infarction, and four patients required reoperation, one for an anastomotic leak. No patient failed to receive EB-IORT because of operative complications during the time period of this study. CONCLUSION: Adjuvant EB-IORT after pancreaticoduodenectomy can be delivered safely, with low mortality and acceptable morbidity.


Subject(s)
Adenocarcinoma/diagnostic imaging , Adenocarcinoma/surgery , Pancreatic Neoplasms/diagnostic imaging , Pancreatic Neoplasms/surgery , Pancreaticoduodenectomy , Adult , Aged , Combined Modality Therapy , Female , Follow-Up Studies , Humans , Intraoperative Period , Male , Middle Aged , Pancreaticoduodenectomy/adverse effects , Postoperative Complications/mortality , Radiography
9.
Med Phys ; 19(5): 1255-61, 1992.
Article in English | MEDLINE | ID: mdl-1435606

ABSTRACT

In order to initiate the use of a multileaf collimator (MLC) in the clinic, a set of technical procedures needs to be available sufficient to create MLC leaf settings and to deliver an accurate dose of radiation through the MLC-shaped field. Dosimetry data for clinical use of the MLC were measured. Dosimetric characteristics included central axis percent depth dose, output factors, and penumbra. In this paper, it has been concluded that a dose control monitor unit calculation procedure that has been applied to the use of conventional secondary field-shaping blocks can be applied to the multileaf collimator dosimetry. The multileaf collimator penumbra (20% to 80%) is only slightly wider (1-3 mm) than the penumbra of the conventional collimator jaws. Beam's-eye-view comparisons made between the isodose curves in fields shaped by conventional Cerrobend blocks and isodose curves in fields shaped by the multileaf collimator demonstrated that the 50% isodose line at 10-cm depth exhibited the discrete steps of the multileaf collimator leaves, but that the 90% and 10% isodose curves of the multileaf were close to those shaped by Cerrobend blocks.


Subject(s)
Radiotherapy Dosage , Radiotherapy/methods , Humans , Mathematics , Models, Theoretical
10.
Med Phys ; 19(1): 187-94, 1992.
Article in English | MEDLINE | ID: mdl-1620046

ABSTRACT

In a beam accessory configuration for a linear accelerator using a prototype multileaf collimator, newly designed wedges were mounted beyond the blocking tray. The isodose curves, depth of maximum dose, surface dose, and wedge transmission factors were measured for the wedges designed for this unique configuration. The same set of wedges was used for both 6- and 18-MV x rays. The shape of the wedged isodose curves was essentially unchanged from those produced by the conventional wedges located above the blocking tray. The isodose curves exhibited the desired wedge angles over the range of field sizes from 5 x 5 to 15 x 40 cm. In the 10 x 10-cm field, the average difference between the observed wedge angle and the desired wedge angle was 3.8 degrees. The surface doses ranged from 18% to 35% for the wedged 10 x 10-cm fields as compared with about 15% for the same open field. Dosimetrically the wedges were acceptable for clinical use.


Subject(s)
Models, Anatomic , Radiotherapy Planning, Computer-Assisted/methods , Radiotherapy/instrumentation , Humans , Particle Accelerators
11.
Int J Radiat Oncol Biol Phys ; 21(2): 501-10, 1991 Jul.
Article in English | MEDLINE | ID: mdl-2061127

ABSTRACT

Dosimetry data were obtained on the first dedicated linear accelerator of its type designed for electron intraoperative radiotherapy (IORT) within an operating room. The linear accelerator uses a high dose rate, 9 Gy.min-1, to reduce the treatment time. Its chrome-plated brass treatment cones, designed with straight ends and 22.5 degrees beveled ends, are not mechanically attached to the collimator head, but are aligned using a laser projection system. Dosimetry measurements were made for each combination of energy (6, 9, 12, 15, and 16 MeV), cone size (diameters range from 5 to 12 cm), and cone type (22.5 degrees beveled or straight). From these data, depth-dose curves, cone output, and air-gap correction factors were generated that allow the calculation of the monitor setting for delivering a prescribed dose at any depth for any irradiation condition (energy, cone, air gap). Isodose data were measured for every cone using film in a solid water phantom. Scatter off the inside wall of the cone resulted in peripheral dose horns near the surface that were energy and cone dependent, being as large as 120%.


Subject(s)
Electrons , Operating Rooms , Particle Accelerators/instrumentation , Humans , Intraoperative Period , Radiotherapy Dosage
12.
Int J Radiat Oncol Biol Phys ; 18(5): 1223-32, 1990 May.
Article in English | MEDLINE | ID: mdl-2347729

ABSTRACT

A set of circular collimators and treatment cones from 5 to 12 cm diameter has been designed for an intraoperative accelerator (6-18 MeV) that has an optical docking system. Electron beam scattering theory has been used to minimize their weight while minimizing leakage radiation. Both acrylic and brass were evaluated as possible materials; however, because of substantial electron leakage through the lateral cone wall for acrylic, we have concluded that 2 mm thick brass walls are more desirable than acrylic walls. At 18 MeV, isodose measurements beneath the cones showed hot spots as great as 120% for both materials. The placement and dimension of an internal trimmer ring inside the brass cone was studied as a method for reducing the hot spots, and it was found this could only be accomplished at the expense of decreasing coverage of the 90% isodose surface. The effects of 1 degree cone misalignment on the dose distribution has been studied and found to generate changes of less than 5% in the dose and 3 mm in position of the 90% isodose surface. In a study of the contribution of the cone and its matching collimator assembly to x-ray room leakage, it was noted that although the treatment cone had a negligible contribution, the upper annuli of the upper collimator assembly contributed as much as 80% of the leakage at 16 MeV for the 5-cm cone.


Subject(s)
Particle Accelerators/instrumentation , Radiation Protection/instrumentation , Humans , Intraoperative Period , Radiometry , X-Rays
13.
Int J Radiat Oncol Biol Phys ; 18(5): 1215-21, 1990 May.
Article in English | MEDLINE | ID: mdl-2112121

ABSTRACT

The leakage radiation characteristics of a dedicated intraoperative radiotherapy linear accelerator have been measured on a machine designed to minimize the shielding required to allow it to be placed in an operating room suite. The scattering foil design was optimized to produce a flat beam for the field sizes employed while generating minimal bremsstrahlung contamination over the available energy range. More lead shielding was used in the treatment head than is used in conventional accelerators. A small amount of borated polyethylene shielding was also employed since neutron production was present at measurable levels. The room shielding installed in the operating room was demonstrated to be adequate to treat at least 20 patients each month to an average dose of 20 Gy. The worst case exposure was found to be 73% maximum permissible exposure. Administrative control was required for adjoining areas when calibrations and maintenance were performed.


Subject(s)
Operating Rooms , Particle Accelerators , Radiation Protection , Radiotherapy, High-Energy , Intraoperative Period , Neutrons , Radiation Protection/instrumentation , Radiotherapy, High-Energy/instrumentation , X-Rays
SELECTION OF CITATIONS
SEARCH DETAIL
...